NEURACEQ
Google image searchProduct monograph
Active ingredient
florbetaben (18f), 5000 MBq/ML
DIN: 02461927
Dosage form(s): SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.
Date: 13-AUG-2018
ATC:
- V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
- V09A — CENTRAL NERVOUS SYSTEM (ATC, ATC/DDD)
- V09AX — Other central nervous system diagnostic radiopharmaceuticals (ATC, ATC/DDD)
- V09AX06 — FLORBETABEN 18F (ATC/DDD)
